Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site

Abstract

We have previously shown that loss of heterozygosity (LOH) on human chromosome (hchr) 7 at q31.1 is common in a variety of tumors of epithelial origin. Frequent LOH of a specific chromosomal marker is indicative of a closely linked tumor suppressor gene (TSG). However, recent reports have also indicated that such a high frequency of LOH could be due to the presence in this region of the second most common aphidicolin-inducible fragile site in the human genome (Fra7G). To address this controversy, we introduced single copies of hchr7 or hchr12 into a highly aggressive human prostate carcinoma cell line (PC3) by microcell-mediated transfer. The tumorigenicity of six clones of PC3/hchr7 hybrids and three clones of PCRhchr12 hybrids, obtained in four separate fusion experiments, were studied in BALB/c nude mice. All but one of the PC3/hchr7 hybrids increased tumor latency by at least twofold, whereas none of the PC3/hchr12 hybrids delayed tumor onset. No differences in the in vitro growth rate were observed among any of the cell lines assayed (parental and hybrids) suggesting that the observed tumor suppression was due to factors other than cell cycle regulation. Deletion mapping of the PC3/hchr7 tumors obtained after reversion to the malignant phenotype revealed a common region of loss centred around 7q31.1, supporting the TSG hypothesis. The smallest commonly deleted region was 1.5 Mb in size and flanked by the markers D7S486 and D7S655.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Abbreviations

LOH:

loss of heterozygosity

TSG:

tumor suppressor gene

hchr:

human chromosome

References

  • Achille A, Biasi MO, Zamboni G, Bogina G, Magalini AR, Pederzoli P, Perucho M and Scarpa A . 1996 Cancer Res 56: 3808–3813

  • Bieche I, Champeme MH, Matifas F, Hacene K, Callahan R and Lidereau R . 1992 Lancet 339: 139–143

  • Cheng Y, Poulos NE, Lung ML, Hampton G, Ou B, Lerman MI and Stanbridge EJ . 1998 Proc Natl Acad Sci USA 95: 3042–3047

  • Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, Qian J, Takahashi S and Jenkins RB . 1996 Cancer Res 56: 4475–4482

  • Ewing CM, Ru N, Morton RA, Robinson JC, Wheelock MJ, Johnson KR, Barrett JC and Isaacs WB . 1995 Cancer Res 55: 4813–4817

  • Gupta PK, Sahota A, Boyadjiev SA, Bye S, Shao C, O'Neill JP, Hunter TC, Albertini RJ, Stambrook PJ and Tischfield JA . 1997 Cancer Res 57: 1188–1193

  • Huang H, Qian C, Jenkins RB and Smith DI . 1998b Genes Chromo Cancer 21: 152–159

  • Huang H, Qian J, Proffit J, Wilber K, Jenkins R and Smith DI . 1998a Oncogene 16: 2311–2319

  • Huebner K, Hadaczek P, Siprashvili Z, Druck T and Croce CM . 1997 Biochim Biophys Acta 1332: M65–M70

  • Kaighn ME, Lechner JF, Narayan KS and Jones LW . 1978 Natl Cancer Inst Monogr 49: 17–21

  • Koike M, Takeuchi S, Yokota J, Park S, Hatta Y, Miller CW, Tsuruoka N and Koeffler HP . 1997 Genes Chromo Cancer 19: 1–5

  • Kuniyasu H, Yasui W, Yokozaki H, Akagi M, Akama Y, Kitahara K, Fujii K and Tahara E . 1996 Int J Cancer 59: 597–600

  • Matsuda T, Sasaki M, Kato H, Yamada H, Cohen M, Barrett JC, Oshimura M and Wake N . 1997 Oncogene 15: 2773–2781

  • Neuman WL, Rubin CM, Rios RB, Larson RA, LeBeau MM, Rowley JD, Vardiman JW, Schwartz JL and Farber RA . 1992 Blood 79: 1501–1510

  • Nishizuka S, Tamura G, Terashima M and Satodate R . 1997 Br J Cancer 76: 1567–1571

  • Oakahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN and Jenkins RB . 1995 Cancer Res 55: 4114–4119

  • Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M and Oishi M . 1993 Mol Cell Biol 13: 6036–6043

  • Sanchez Y, Lovell M, Marin MC, Wong PE, Wolf-Ledbetter ME, McDonnell TJ and Killary AM . 1996 Proc Natl Acad Sci USA 93: 2551–2556

  • Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J and Smith DI . 1997 Oncogene 15: 2727–2733

  • Szeles A, Yang Y, Sandlund AM, Kholodnyuk I, Kiss H, Kost-Alimova M, Zabarovsky ER, Stanbridge E, Klein G and Imreh S . 1997 Genes Chromo Cancer 20: 329–336

  • Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G and Lathrop MA . 1992 Nature 359: 794–801

  • Zar JH . 1996 Biostatistical Analysis Chapter 16 Prentice-Hall Upper Saddle River, NJ, USA pp162–184

    Google Scholar 

  • Zenklusen JC and Conti CJ . 1996 Mol Carcinog 15: 167–175

  • Zenklusen JC, Bieche I, Lidereau R and Conti CJ . 1994a Proc Natl Acad Sci USA 91: 12155–12158

  • Zenklusen JC, Oshimura M, Barrett JC and Conti CJ . 1994c Oncogene 9: 2817–2825

  • Zenklusen JC, Thompson JC, Klein-Szanto AJ and Conti CJ . 1995b Cancer Res 55: 1347–1350

  • Zenklusen JC, Thompson JC, Troncoso P, Kagan J and Conti CJ . 1994b Cancer Res 54: 6370–6373

  • Zenklusen JC, Weintraub LA and Green ED . 1999 Neoplasia 1: 16–22

  • Zenklusen JC, Weitzel JN, Ball HG and Conti CJ . 1995a Oncogene 11: 359–363

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zenklusen, J., Hodges, L., LaCava, M. et al. Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site. Oncogene 19, 1729–1733 (2000). https://doi.org/10.1038/sj.onc.1203488

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203488

Keywords

This article is cited by

Search

Quick links